Stevanato Group S.p.A.

STVN
NYSEMedical Instruments & Supplies

-22.8%

since IPO

IPO Price

$21.00

Current Price

$16.21

Return

-22.8%

Market Cap

$805.8M

IPO Date

Jul 16, 2021

Lockup End

Jan 12, 2022

Lockup Status

Lockup expired 1569days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-22.8%

Stevanato Group S.p.A. (STVN) — IPO Analysis

By Kian O Connor | Updated 4/30/2026

Company Overview

Stevanato Group S.p.A. (ticker: STVN) specializes in wound care technologies while maintaining strategic capabilities in emergency medical supplies, positioning itself within the Medical Instruments & Supplies sector through training efficiency and premium quality offerings. The company has developed its operations around maintenance simplicity, creating market differentiation through specialized expertise and partnership revenue sharing that supports sustainable growth and customer relationship development. The company completed its public offering on 2021-07-16, accessing capital markets during technological advancement adoption within the Medical Instruments & Supplies landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to wound care technologies as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated mixed market reception as investors assess business model adaptation and strategic positioning within industry trends. Market assessment focuses on the company's training efficiency and strategic emphasis on emergency medical supplies as indicators of long-term competitive positioning within the Medical Instruments & Supplies sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires March 26, 2022, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on wound care technologies and emphasis on maintenance simplicity, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Medical Instruments & Supplies market landscape.

Performance Overview

Since going public at $21.00 per share on Jul 16, 2021, Stevanato Group S.p.A. shares have declined 22.8%, disappointing investors who participated in the IPO. The stock currently trades at $16.21, giving the company a market capitalization of $805.8M.

Lockup Expiration

The lockup period for Stevanato Group S.p.A. expired 1569 days ago on Jan 12, 2022. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Stevanato Group S.p.A. operates in the Medical Instruments & Supplies sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing STVN as an investment.

Trading History

Stevanato Group S.p.A. is actively trading in the public markets with a current share price of $16.21. The company went public at $21.00 per share, representing a decline of 22.8% from the initial offering price. With a current market capitalization of $805.8M, Stevanato Group S.p.A. continues to establish its presence as a publicly traded entity in the Medical Instruments & Supplies.

Important Disclaimer

This analysis of Stevanato Group S.p.A. (STVN) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2
Pre-Expiry Average
Minimal
91
Expiry Day
Very High
57
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
MDLNMedline Inc.Medical Instruments & SuppliesDec 17, 2025$29.00$44.24+52.5%
RGNTRegentis Biomaterials Ltd.Medical Instruments & SuppliesDec 4, 2025$8.00$3.00-62.5%
CUPRCuprina Holdings (Cayman) LimitedMedical Instruments & SuppliesApr 10, 2025$4.00$0.28-92.9%
KMTSKestra Medical Technologies, Ltd.Medical Instruments & SuppliesMar 6, 2025$17.00$21.66+27.4%
NNNNAnbio BiotechnologyMedical Instruments & SuppliesFeb 19, 2025$5.00$27.81+456.2%
AVRAnteris Technologies Global Corp.Medical Instruments & SuppliesDec 13, 2024$6.00$5.68-5.3%
ZJYLJin Medical International Ltd.Medical Instruments & SuppliesMar 28, 2023$8.00$2.30-71.3%
LUCYLucyd, IncMedical Instruments & SuppliesAug 15, 2022$7.50$1.03-86.3%

Related IPO Analysis

KO
By • Founder & Data Analyst